China Top 60 Biopharmaceutical Manufacturing Directory - Second Edition
|発行||BioPlan Associates, Inc.||商品コード||753441|
|出版日||ページ情報||英文 366 Pages
|中国におけるバイオ医薬品メーカー上位60社のディレクトリ China Top 60 Biopharmaceutical Manufacturing Directory - Second Edition|
|出版日: 2017年02月28日||ページ情報: 英文 366 Pages||
当レポートでは、中国のバイオ医薬品施設について調査分析し、詳細なプロファイル (生産能力、歴史、製品、規模、経営、ビジネスフォーカス、製品、R&D、事業・提携戦略、強みと弱み、将来目標など) のほか、既存・将来の施設、上市・治験製品に関する情報も含めて、体系的な情報を提供しています。
The completely updated, comprehensive Top 60 Directory provides detailed profiles of China biopharmaceutical facilities, including information on their capacity, history, products, scale, management, business focus, products, R&D, business and partnering strategies, strengths and weaknesses, and future objectives. The directory also highlights current and upcoming facilities, and includes information on key marketed and clinical trial products.
“Top 60 Biopharmaceutical Facilities in China Directory” allows readers to keep up-to-date on new and existing biopharmaceutical facilities as the industry continues to grow and expand. This newly updated directory helps you stay aware of current key participants, as well as new and upcoming facilities in this rapidly changing market.
This second edition of BioPlan Associates' facilities directory of major biopharmaceutical manufacturing facilities in China covers facilities with the most bioprocessing capacity (total bioreactor volumes), and those under active construction. Facility information includes:
The ranking of companies is based on facility factors including aspects such as:
The Directory also is available as a regularly updated online database featuring monthly updates, new data, re-ranked facilities, and vital capacity, build-out, and staffing information.
Vicky Qing XIA, Sr. Project Manager.
MS Biology University of Texas, MBA University of Pittsburgh, has extensive experience in alliance management in China's bio-pharmaceutical industry; has worked with major biopharma facilities in US and China. Her expertise includes analysis of global markets; she also authors biotech publications and newsletters.
Yibing (Eliza) Zhou, Project Director, China.
Yibing Zhou manages pharmaceutical and biotechnology programs in China. She is an editor and author for “Advances in Biopharmaceutical Technology in China” by BioPlan and the Society for Industrial Microbiology. Ms. Zhou holds a Bachelor of Pharmaceutical Chemistry (1987) from the West China University of Medical Sciences (merged into Sichuan University in 2001).